Listen Now
Topics Covered
- Overview of Bladder Cancer, Including Staging and Grading, in the Context of COVID, Seasonal Flu & RSV
- Standard of Care
- New Treatment Approaches
- Update on Clinical Trials
- The Role of Diagnostic Technologies, Genomics & Precision Medicine
- Targeted Treatments: Predicting Response to Treatment
- The Role of Immunotherapy
- Communicating with Your Health Care Team About Quality-of-Life Concerns
- Follow-Up Care Appointments and Plans
- Guidelines to Prepare for Telehealth/Telemedicine Appointments, Including Technology, Prepared List of Questions & Discussion of OpenNotes
- Nutrition & Hydration Concerns & Tips
- Questions to Ask Our Panel of Experts
Our Panel of Experts
Randy F. Sweis, MD
Physician-Scientist, Assistant Professor of Medicine, Committee on Cancer Biology, Committee on Clinical Pharmacology and Pharmacogenomics, Committee on Immunology, Biological Sciences Division, The University of Chicago
Vignesh T. Packiam, MD
Associate Professor of Urologic Oncology, Director of GU Clinical and Translational Research, Rutgers Cancer Institute of New Jersey, Rutgers Robert Wood-Johnson University Medical School
Diana L. Bearden, MS, RD, CSO, LD, CNSC
Oncology Dietitian, Michael E. DeBakey VA Medical Center
Patricia Rios, MBA, MPH
Senior Education & Advocacy Manager, Bladder Cancer Advocacy Network
Carolyn Messner, DSW, BCD, FAPOS, FAOSW
Senior Director of Education and Training, CancerCare
Brochure
You can download the brochure for this workshop
Workshop Date
This workshop was originally recorded on January 24, 2024.